Aluminum forms in drinking water and risk of Alzheimer's disease

Environmental Research

Volumn 84, Issue 3, 2000, Pages 234-246

  Gauthier, Eric ^a   Fortier, Isabel ^a,b   Courchesne, Francois ^a   Pepin, Paul ^a   Mortimer, Jim ^c   Gauvreau, Denis ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Algène Biotechnologies Corp   (Canada)

^c UNIVERSITY OF TAMPA   (United States)

Author keywords

Aluminum speciation; Alzheimer's disease; Confounding factors; Long term exposure; Residential history

Indexed keywords

ALUMINUM; ALUMINUM FLUORIDE; ALUMINUM HYDROXIDE; ALUMINUM SILICATE; ALUMINUM SULFATE; APOLIPOPROTEIN E; DRINKING WATER;

ALUMINUM; DRINKING WATER; POLLUTION EXPOSURE;

AGED; ALLELE; ALZHEIMER DISEASE; CANADA; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATION; ENVIRONMENTAL EXPOSURE; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUALITY CONTROL; WATER ANALYSIS;

CANADA; QUEBEC; SAGUENAY-LAC-SAINT-JEAN;

ANIMALIA;

EID: 0033637208     PISSN: 00139351     EISSN: None     Source Type: Journal    
DOI: 10.1006/enrs.2000.4101     Document Type: Conference Paper

References (110)

1. De la recherche a la pratique: Actes de l'atelier sur le defi de la demence au Canada
2. Le paradigme de la maladie d'Alzheimer
3. The genetic defect causing familial Alzheimer's disease maps on chromosome 21
4. Genetic linkage evidence for a familial Alzheimer's disease locus chromosome 14
5. A familial Alzheimer's disease locus on chromosome 1
6. A locus for familial early onset Alzheimer's disease on the long arm of chromosome 14 proximal to the alpha1 antichymotrypsin gene
7. Cloning of a gene bearing misssense mutations in early-onset familial Alzheimer's disease
8. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene
9. Linkage studies in familial Alzheimer disease: Evidence for chromosome 19 linkage
10. ApoE allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia
11. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
12. Evidence for ApoE ε4 association in early-onset alzheimer's disease patients with late onset relatives
13. Researchers find evidence of a new gene for late-onset Alzheimer disease
14. Familial aggregation of Alzheimer's disease and related disorder: A collaborative reanalysis of case-control studies
15. Molecular genetics of Alzheimer disease: Identification of genes and gene mutations
16. Review of epidemiologic studies of aluminium and neurologic disorders
17. Aluminum: Neurofibrillary degeneration and Alzheimer disease
18. Mise en evidence de l'aluminium dans les plaques seniles de la maladie d'Alzheimer: Etude a la micro-sonde de Castaing
19. Aluminsilicate and senile plaque formation in Alzheimer's disease
20. Aluminum and the etiopathogenesis of Alzheimer's disease
21. Would decreased aluminum ingestion reduce the incidence of Alzheimer's disease?
22. Alzheimer's disease: X-ray spectrometric evidence of aluminium accumulation in neuro-fibrillary tangle bearing neurons
23. Laser microprobe mass analyser (LAMMA) - A new approach to the study of the association of aluminum and neurofibrillary tangle formation
24. Selective accumulation of aluminum and iron in neurofibrillary tangles of Alzheimer's disease: A laser microprobe (LAMMA) study
25. Neuronal origin of a cerebral amyloid: Neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque core and blood vessels
26. Aluminum levels in brain in Alzheimer's disease
27. Brain aluminum in Alzheimer's disease and aging
28. Intrumental neutron activation analysis of brain aluminum in aging and Alzheimer's disease
29. Brain destruction alone does not elevate brain aluminum
30. A re-examination of Al in AD: Analysis by energy dispersive X-ray microprobe and flameless atomic absorption spectrophotometry
31. Absence of aluminum in Alzheimer's disease brain tissue, Electron microprobe and ion microprobe studies
32. Absence of aluminum in neuritic plaque core in Alzheimer's disease
33. Laser microprobe analysis of brain aluminum in Alzheimer's disease
34. Aluminium and the risk for Alzheimer's disease
35. Origin and resolution of the aluminum controversy concerning Alzheimer's neurofibrillary degeneration
36. Neutron activation analysis techniques for identifying elemental status in Alzheimer's disease
37. Content of brain aluminum is not elavated in Alzheimer disease
38. Geographical relation between Alzheimer's disease and aluminium in drinking water
39. Geographical associations between aluminium in drinking water and death rates with dementia (including Alzheimer's disease), Parkinson's and Amyotrophic lateral sclerosis in Norway
40. Study of the relationship between Alzheimer's disease and aluminum in drinking water
41. Aluminum, Alzheimer's disease, and drinking water
42. Components of drinking water and risk of cognitive impairment in the elderly
43. Geochemical risk factors for mental functioning, based on the Ontario longitudinal study of aging (LSA) V. Comparisons of the results, relevant to aluminum water concentrations, obtained from LSA and from death certificates mentioning dementia
44. Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories
45. Silica and aluminum in drinking water and cognitive impairment in the elderly
46. Bone mass and dementia in hip fracture patients from areas with different aluminium concentrations in water supplies
47. Failure to find a relationship between mnestic skills of octogenarians and aluminium in drinking water
48. Alzheimer's disease and the relationship between silicon and aluminium in water supplies in northern England
49. Aluminum concentrations in drinking water and risk of Alzheimer's disease
50. Comments on aluminum in drinking water
51. The modified Mini-Mental State (3MS) examination
52. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II: Standardisation of the neuropathological assessment of Alzheimer's disease
53. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
54. The measurement of observer agreement for categorical data
55. Concordance of occupational and environmental exposure information elicited from patients with AD and surrogate respondents
56. Environmental trace analyses with the stabilized temperature platform furnace and Zeeman background correction
57. An automatic method for fractionation and determination of aluminum species in fresh-waters
58. ALCHEMI: A chemical equilibrium model to assess the acid-base chemistry and speciation of aluminum in dilute solutions
59. Latency and time-dependent exposure in a case-control study
60. Citrate: A major factor in the toxicity of orally administered aluminum compounds
61. Gastrointestinal absorption of aluminium in Alzheimer's disease: Response to aluminium citrate
62. Effect of various dietary constituents on gastrointestinal absorption of aluminum from drinking water and diet
63. The chemistry of aluminum as related to biology and medicine
64. Site and mechanism of enhanced gastrointestinal absorption of aluminum by citrate
65. Iron status affects aluminum uptake and transport by Caco-2 cells
66. The chemistry of aluminum as related to biology and medicine
67. Aluminum toxicokinetics
68. The distribution of aluminum into and out of the brain
69. Aluminum metabolism
70. Gastrointestinal absorption of aluminum from single doses of aluminum containing antacids in man
71. Speciation and bioavailability of aluminum in drinking water
72. Inter-subject variability in the metabolism of aluminium following intravenous injection as citrite
73. Uptake of trace amounts of alumnium into the brain from drinking water
74. Genetic influences on tissue deposition of aluminum in mice
75. The chemistry of aluminum in the environment
76. Geographical association between drinking water chemistry and the mortality and morbidity of cancer and some other diseases in Norway
77. Recovery of a deforested ecosystem
78. Effect of base cation addition on soil chemistry in sugar maple forest of the Lower Laurentians, Quebec
79. Aqueous chemistry of aluminum
80. Aluminum, water chemistry, and Alzheimer disease
81. Polynuclear aluminum and acute toxicity in the fish
82. Effect of silicon on gastrointestinal absorption of aluminium
83. Solubility characteristics of proto-imogolite sols: How silicic acid can de-toxify aluminium solutions
84. Silicic acid and the biological availability of aluminium
85. Aluminum, its absorption, distribution, and effects on phosphorous metabolism
86. Effect of aluminum hydroxide on plasma fluoride and fluoride excretion during a high fluoride intake in man
87. Canadian Study of Health and Aging: Risk factors for Alzheimer disease in Canada
88. History of dementia and Parkinson's disease in first-degree relatives of patients with Alzheimer's disease
89. A case-control study of Alzheimer's disease
90. Molecular genetics of Alzheimer disease: Identification of genes and gene mutations
91. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's